ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 66 filers reported holding ONCOCYTE CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $77,686 | +46141.7% | 337,765 | -28.8% | 0.00% | – |
| Q1 2023 | $168 | -6.7% | 474,711 | -15.4% | 0.00% | – |
| Q4 2022 | $180 | -100.0% | 561,361 | -22.2% | 0.00% | – |
| Q3 2022 | $527,000 | -41.2% | 721,386 | -27.6% | 0.00% | -100.0% |
| Q2 2022 | $896,000 | +192.8% | 996,169 | +606.2% | 0.00% | – |
| Q4 2021 | $306,000 | -71.3% | 141,064 | -52.8% | 0.00% | -100.0% |
| Q3 2021 | $1,065,000 | -65.4% | 299,172 | -44.1% | 0.00% | -50.0% |
| Q2 2021 | $3,074,000 | +1.3% | 535,560 | -8.4% | 0.00% | 0.0% |
| Q1 2021 | $3,035,000 | +2099.3% | 584,778 | +912.7% | 0.00% | – |
| Q4 2020 | $138,000 | +146.4% | 57,746 | +43.2% | 0.00% | – |
| Q3 2020 | $56,000 | -46.7% | 40,331 | -19.4% | 0.00% | – |
| Q3 2019 | $105,000 | -52.7% | 50,061 | -43.9% | 0.00% | – |
| Q2 2019 | $222,000 | -75.4% | 89,246 | -60.9% | 0.00% | -100.0% |
| Q1 2019 | $903,000 | +1043.0% | 228,532 | +623.6% | 0.00% | – |
| Q3 2018 | $79,000 | -75.0% | 31,583 | -74.5% | 0.00% | – |
| Q2 2018 | $316,000 | +101.3% | 123,812 | +370.0% | 0.00% | – |
| Q1 2017 | $157,000 | +220.4% | 26,343 | +145.7% | 0.00% | – |
| Q1 2016 | $49,000 | – | 10,721 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 1,093,219 | $6,833,000 | 1.15% |
| HUNTINGTON NATIONAL BANK | 10 | $0 | 0.00% |
| CITIGROUP INC | 642 | $4,000 | 0.00% |
| Sonora Investment Management, LLC | 50 | $0 | 0.00% |
| BARCLAYS PLC | 206 | $1,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 96 | $1,000 | 0.00% |